Jefferies Maintains a 'Buy' on ViroPharma (VPHM); Major Setback with SC Cinryze Using HALO Technology

August 2, 2012 11:01 AM EDT Send to a Friend
Jefferies maintains a 'Buy' on ViroPharma (NASDAQ: VPHM) price target of $32.00 (from $23.00).

Analyst, Thomas Wei, said, "VPHM ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login